What Is In Vitro Diagnostics? And Why Your Hospital Keeps Ordering the Wrong Products
It was 4:42 PM on a Thursday when the call came in.
A procurement coordinator from a regional hospital, her voice doing that thing where forced calm barely covers panic.
"We need 30 self-caths by Monday morning. Coloplast. The female one."
I asked, "Which exact model?"
Silence.
"They're the ones with the green packaging."
That's when I knew this was going to cost someone time and money.
The product she needed was the Coloplast Self Cath Plus Female Catheter 4210. What she'd asked for could have been any one of nine different catheters Coloplast makes. "Green packaging" narrowed it down a little, but not enough. We sorted it out. Not by noon, and not without a rush fee.
That call is a microcosm of what I see two or three times a month. And it took me about four years and 200-plus rush orders to understand what was really going on.
The Problem Isn't the Rush Order
The problem is the category confusion that makes the rush order necessary in the first place.
In my role coordinating emergency medical supply deliveries for hospitals, clinics, and home care networks, I've handled around 300 rush orders in 8 years. Actually, 287, I'd have to check the system. The pattern is consistent: the order itself is rarely the problem. The problem is that the person placing the order doesn't understand the category they're ordering from.
Medical devices are not commodities. And when they get treated like commodities, everything falls apart.
What In Vitro Diagnostics Actually Is
One of the biggest category failures I see involves in vitro diagnostics—IVD for short.
In vitro diagnostics refers to tests and systems that analyze biological samples—blood, urine, tissue—outside the body. That's what "in vitro" means: in glass, in a controlled environment, not injected or ingested into a patient.
Your hospital chemistry analyzer is IVD. Hematology analyzers, immunoassay systems, PCR platforms—all IVD.
These systems tell you what's happening in a patient's body. They aren't treatment devices. They don't deliver therapy. They don't come in contact with the patient at all. The sample goes in. The result comes out. Based on that result, a clinician decides what to do next.
This sounds basic. But I've watched seasoned procurement professionals treat a chemistry analyzer order the same way they'd treat an order for a hospital bed.
It's not the same.
A hospital bed is a commodity. It gets unboxed, assembled, rolled into a room. Even if the model is slightly different from what was ordered, the clinical impact is minimal. A chemistry analyzer is a different story: it requires controlled installation, calibration, reagents, training of lab staff, and a validation process that takes significant time. If the wrong analyzer or a missing component gets installed, the system goes unused. And it was already paid for.
One Catheter: Six Variations That Look Alike
Now consider a product that looks deceptively simple.
The Coloplast Self Cath Plus Female Catheter 4210 is a specific intermittent catheter designed for female anatomy. Compact introducer tip. A particular length and diameter. It's engineered for daily self-catheterization.
If a procurement coordinator emails "Coloplast female catheter, 30 units" without a model number, I have to pause. Because the Coloplast catalog lists at least six versions that match that description.
Why does this matter? Because catheter length, tip design, diameter, and insertion mechanism aren't cosmetic differences. They affect whether the product works correctly for the specific patient using it. A catheter that's the wrong size or configuration isn't just uncomfortable—it can cause clinical complications.
The easiest way to get it right: the Coloplast logo and the model number are printed together on the product packaging. The logo verifies the source. The model number verifies the product. In my experience, people check the logo and skip the model number. That inversion is exactly where the confusion begins.
What This Confusion Costs
Let's put numbers on it.
Rush fees for medical devices typically run from $200 to $900 per order, depending on package dimensions, distance, and whether delivery falls on a weekend or holiday. But the rush fee is rarely the largest cost.
The cascade continues like this:
- Reordering. A new order batch, another round of shipping fees, and 3–7 business days of lead time. If a patient is waiting for discharge, those days count double.
- Patient care delays. The hospital absorbs the cost of a continued stay—sometimes for days—because a home-care device arrived with the wrong specification.
- Return or disposal. Single-use medical devices aren't always eligible for restocking once they've left the warehouse. Sometimes they're simply discarded.
- Staff hours. Procurement time, nursing time, distributor time. I've seen entire afternoons spent on "did we order the right green one?"
I don't have hard data on nationwide hospital losses to product-category confusion. But I can give you my own numbers: roughly 15% of my operation's rush-order volume traces back to an under-specified order at the moment of submission. For my team, that's 35 to 40 orders a year, each with emergency shipping costs and hidden hospital labor. Scale that across every distributor in the country.
And there's a deeper version of the same problem.
In 2021, my company lost a $300,000 contract because we tried to be everything to a client. The RFP had two parts: a urology patient education program, which is our strength, and point-of-care IVD equipment—specifically a chemistry analyzer for a new clinic. We included the IVD system with resale pricing and a confident smile.
Then we saw the winning bid. A competitor had written one line about the IVD component: "This is not our area. We'd partner with a diagnostics specialist for that piece."
That single admission made them more credible than our entire polished proposal.
Seeing our bid and theirs side by side made me realize something: boundaries aren't weaknesses in procurement. They're signals of honesty.
What Actually Works: A Saner Procurement Model
If you work in healthcare procurement, here's what I'd recommend:
- Separate categories before you tender. IVD equipment belongs in its own procurement lane with its own lab-medicine stakeholders. Catheter and continence products belong in their own lane. Commodities like standard hospital beds can be volume-purchased with simple specifications.
- Demand model numbers, always. If a supplier can't put the exact product code on the invoice, that's a red flag.
- Check the packaging. The Coloplast logo and model number appear together. If one is missing, stop and verify the product before it reaches a patient.
- Ask suppliers what they don't do. Per FTC advertising guidelines, commercial claims should be truthful and substantiated. A supplier who openly says "this isn't our specialty" is being truthful, and that honesty typically extends to everything else they sell.
None of this is complicated. It's just a shift in how you look at the problem.
The Bottom Line
I coordinate emergency orders. I can get almost any product to almost any facility within 48 hours. That's what our operation is built for.
Rushing a well-specified order is what we should be good at.
Rushing an under-specified order is a different risk category. And honestly, many of those orders never should have been urgent to begin with.
The next time someone hands you a requisition for a "Coloplast self cath" or a "chemistry analyzer" with nothing more specific, slow down.
Ask the question that costs nothing: "Which exact model?"
In medical procurement, those four words are the difference between a smooth delivery and an expensive lesson.